Founded in 2017, PELL Bio-Med Technology Co., Ltd. is a Taiwan-based biotechnology company specializing in cell culture technology and cell therapy applications.
Led by Professor Steve C.L. Lin, a globally renowned immunologist and Fellow of the Royal College of Surgeons (FRCS), PELL is committed to advancing healthcare through innovation. With roots in groundbreaking research at the University of Oxford, Professor Lin brings over two decades of expertise in cancer immunotherapy and stem cell therapy to the company.
Headquartered in Neihu Science Park, Taipei, with a branch office in Kaohsiung, PELL collaborates with leading research institutions worldwide. Guided by the values of health, care, precision, and professionalism, PELL is dedicated to pioneering advancements in cell therapy and regenerative medicine.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 87 Xinhu 2nd Road, Neihu District,taipei City 11494,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.pellbmt.com/
- Keywords
- CAR-T, Cell therapy, Immunotherapy.
- HQ
- Neihu District, Taipei City
Pell Bmt Questions
Pell Bmt's website is https://www.pellbmt.com/
Pell Bmt's LinkedIn profile is https://tw.linkedin.com/company/pell-bmt
Pell Bmt has
8 employees.
View email and phone details for 8
employees at Pell Bmt.
Pell Bmt's industry is
Biotechnology Research
Pell Bmt's top competitors are
鍇睿行銷 Carry Live Co.,
Pell Biomedical Technology Co,
Geneonline,
Acepodia,
Promise Technology,
Global Bio & Investment Monthly,
Orbitel International,
Health2sync 智抗糖,
Tcmc,
Excellence Finland.
Pell Bmt's categories are Biotechnology Research
Pell Bmt's founding year is 2017
